Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.

Kamran SC, Lennerz JK, Margolis CA, Liu D, Reardon B, Wankowicz SA, Van Seventer EE, Tracy A, Wo JY, Carter SL, Willers H, Corcoran RB, Hong TS, Van Allen EM.

Clin Cancer Res. 2019 Sep 15;25(18):5561-5571. doi: 10.1158/1078-0432.CCR-19-0908. Epub 2019 Jun 28.

PMID:
31253631
2.

Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted Therapies.

Grassberger C, McClatchy D 3rd, Geng C, Kamran SC, Fintelmann F, Maruvka YE, Piotrowska Z, Willers H, Sequist LV, Hata AN, Paganetti H.

Cancer Res. 2019 Jul 15;79(14):3776-3788. doi: 10.1158/0008-5472.CAN-18-3652. Epub 2019 May 21.

PMID:
31113818
3.

Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.

Kamran SC, Light JO, Efstathiou JA.

Prostate Cancer Prostatic Dis. 2019 Apr 9. doi: 10.1038/s41391-019-0140-7. [Epub ahead of print] Review.

PMID:
30967625
4.

Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.

Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e356-e361. doi: 10.1016/j.prro.2019.02.002. Epub 2019 Feb 18.

PMID:
30790717
5.

In response to Letter to the Editor regarding: Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer.

Kamran SC, Qureshi MM, Truong MT.

Laryngoscope. 2019 Mar;129(3):E88-E90. doi: 10.1002/lary.27642. Epub 2018 Dec 12. No abstract available.

PMID:
30548604
6.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
7.

Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up.

Kamran SC, Goldberg SI, Kuhlthau KA, Lawell MP, Weyman EA, Gallotto SL, Hess CB, Huang MS, Friedmann AM, Abrams AN, MacDonald SM, Pulsifer MB, Tarbell NJ, Ebb DH, Yock TI.

Cancer. 2018 Aug;124(16):3390-3400. doi: 10.1002/cncr.31575. Epub 2018 Jun 15.

8.

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.

Kamran SC, Clark JW, Zheng H, Borger DR, Blaszkowsky LS, Allen JN, Kwak EL, Wo JY, Parikh AR, Nipp RD, Murphy JE, Goyal L, Zhu AX, Iafrate AJ, Corcoran RB, Ryan DP, Hong TS.

Cancer Med. 2018 May 17. doi: 10.1002/cam4.1558. [Epub ahead of print]

9.

Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.

Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT.

Head Neck. 2018 Jun;40(6):1174-1184. doi: 10.1002/hed.25087. Epub 2018 Feb 8.

PMID:
29417687
10.

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns' Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e96-e97. doi: 10.1016/j.eururo.2017.12.026. Epub 2018 Jan 19. No abstract available.

PMID:
29358058
11.

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel D. Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer. Eur Urol 2018;73:262-70.

Seisen T, Kamran SC, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Apr;73(4):e100-e101. doi: 10.1016/j.eururo.2017.10.013. Epub 2017 Nov 3. No abstract available.

PMID:
29108659
12.

Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer.

Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT.

Laryngoscope. 2018 Jun;128(6):1353-1364. doi: 10.1002/lary.26903. Epub 2017 Oct 8.

PMID:
28988426
13.

Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.

Kamran SC, Jacene HA, Chen YH, Mauch PM, Ng AK.

Leuk Lymphoma. 2018 Jun;59(6):1384-1390. doi: 10.1080/10428194.2017.1376745. Epub 2017 Sep 22.

PMID:
28937297
14.

MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer.

Kamran SC, Manuel MM, Catalano P, Cho L, Damato AL, Lee LJ, Schmidt EJ, Viswanathan AN.

Brachytherapy. 2017 Nov - Dec;16(6):1159-1168. doi: 10.1016/j.brachy.2017.07.007. Epub 2017 Aug 17.

15.

Characterization of efficacy and toxicity after high-dose pelvic reirradiation with palliative intent for genitourinary second malignant neoplasms or local recurrences after full-dose radiation therapy in the pelvis: A high-volume cancer center experience.

Kamran SC, Harshman LC, Bhagwat MS, Muralidhar V, Nguyen PL, Martin NE, La Follette S, Faso S, Viswanathan AN, Efstathiou JA, Beard CJ.

Adv Radiat Oncol. 2017 Jan 17;2(2):140-147. doi: 10.1016/j.adro.2017.01.001. eCollection 2017 Apr-Jun.

16.

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.

Kamran SC, Seisen T, Markt SC, Preston MA, Trinh QD, Frazier LA, Choueiri TK, Martin NE, Nguyen PL, Beard CJ.

Eur Urol. 2018 Feb;73(2):262-270. doi: 10.1016/j.eururo.2017.06.013. Epub 2017 Jul 4.

PMID:
28687143
17.

Corrigendum to "comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix" [Gynecol. Oncol. 145 (2017) 284-290].

Kamran SC, Manuel MM, Cho LP, Damato AL, Schmidt EJ, Tempany C, Cormack RA, Viswanathan AN.

Gynecol Oncol. 2017 Aug;146(2):440. doi: 10.1016/j.ygyno.2017.05.035. Epub 2017 May 31. No abstract available.

18.

Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.

Kamran SC, Manuel MM, Cho LP, Damato AL, Schmidt EJ, Tempany C, Cormack RA, Viswanathan AN.

Gynecol Oncol. 2017 May;145(2):284-290. doi: 10.1016/j.ygyno.2017.03.004. Epub 2017 Mar 18. Erratum in: Gynecol Oncol. 2017 Aug;146(2):440.

19.

Therapeutic radiation and the potential risk of second malignancies.

Kamran SC, Berrington de Gonzalez A, Ng A, Haas-Kogan D, Viswanathan AN.

Cancer. 2016 Jun 15;122(12):1809-21. doi: 10.1002/cncr.29841. Epub 2016 Mar 7. Review.

20.

Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients.

Kamran SC, Mueller BS, Paetzold P, Dunlap J, Niemierko A, Bortfeld T, Willers H, Craft D.

Radiother Oncol. 2016 Mar;118(3):515-20. doi: 10.1016/j.radonc.2015.12.028. Epub 2016 Jan 28.

PMID:
26830694
21.

Advances in the Management of Gastric and Gastroesophageal Cancers.

Kamran SC, Hong TS, Wo JY.

Curr Oncol Rep. 2016 Feb;18(2):13. doi: 10.1007/s11912-015-0493-6. Review.

PMID:
26769118
22.

miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.

Guda S, Brendel C, Renella R, Du P, Bauer DE, Canver MC, Grenier JK, Grimson AW, Kamran SC, Thornton J, de Boer H, Root DE, Milsom MD, Orkin SH, Gregory RI, Williams DA.

Mol Ther. 2015 Sep;23(9):1465-74. doi: 10.1038/mt.2015.113. Epub 2015 Jun 17.

23.

Nasopharyngeal carcinoma.

Kamran SC, Riaz N, Lee N.

Surg Oncol Clin N Am. 2015 Jul;24(3):547-61. doi: 10.1016/j.soc.2015.03.008. Epub 2015 Apr 11. Review.

PMID:
25979399
24.

Outcomes of proton therapy for the treatment of uveal metastases.

Kamran SC, Collier JM, Lane AM, Kim I, Niemierko A, Chen YL, MacDonald SM, Munzenrider JE, Gragoudas E, Shih HA.

Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1044-50. doi: 10.1016/j.ijrobp.2014.08.003. Epub 2014 Oct 14.

PMID:
25442038
25.

Intrathoracic malignant peripheral nerve sheath tumors: imaging features and implications for management.

Kamran SC, Shinagare AB, Howard SA, Nishino M, Hornick JL, Krajewski KM, Ramaiya NH.

Radiol Oncol. 2013 Jul 30;47(3):230-8. doi: 10.2478/raon-2013-0047. eCollection 2013.

26.

An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.

Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, Shao Z, Canver MC, Smith EC, Pinello L, Sabo PJ, Vierstra J, Voit RA, Yuan GC, Porteus MH, Stamatoyannopoulos JA, Lettre G, Orkin SH.

Science. 2013 Oct 11;342(6155):253-7. doi: 10.1126/science.1242088.

27.

Ifosfamide-induced Fanconi syndrome and desmopressin-responsive nephrogenic diabetes insipidus.

Kamran SC, Pendergraft WF, Harmon DC, Rubin MF.

Am J Med. 2013 Jul;126(7):e7-8. doi: 10.1016/j.amjmed.2013.02.005. Epub 2013 May 16. No abstract available.

PMID:
23684064
28.

Pediatric postoperative intussusception in the minimally invasive surgery era: a 13-year, single center experience.

Klein JD, Turner CG, Kamran SC, Yu AY, Ferrari L, Zurakowski D, Fauza DO.

J Am Coll Surg. 2013 Jun;216(6):1089-93. doi: 10.1016/j.jamcollsurg.2013.01.059. Epub 2013 Apr 6.

PMID:
23571141
29.

Thyroid nodule size and prediction of cancer.

Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, Benson CB, Doubilet PM, Cibas ES, Barletta J, Cho N, Gawande A, Ruan D, Moore FD Jr, Pou K, Larsen PR, Alexander EK.

J Clin Endocrinol Metab. 2013 Feb;98(2):564-70. doi: 10.1210/jc.2012-2968. Epub 2012 Dec 28.

PMID:
23275525
30.

A-Z of malignant peripheral nerve sheath tumors.

Kamran SC, Shinagare AB, Howard SA, Hornick JL, Ramaiya NH.

Cancer Imaging. 2012 Oct 26;12:475-83. doi: 10.1102/1470-7330.2012.0043. Review.

31.

Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.

Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH.

Eur J Surg Oncol. 2013 Jan;39(1):46-52. doi: 10.1016/j.ejso.2012.09.001. Epub 2012 Oct 18.

PMID:
23084090
32.

Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Bauer DE, Kamran SC, Orkin SH.

Blood. 2012 Oct 11;120(15):2945-53. doi: 10.1182/blood-2012-06-292078. Epub 2012 Aug 17. Review.

33.

Day 3 embryo shape as a morphologic selection parameter in in vitro fertilization.

Kamran SC, Reichman DE, Missmer SA, Correia KF, Karaca N, Romano A, Racowsky C.

J Assist Reprod Genet. 2012 Oct;29(10):1135-9. doi: 10.1007/s10815-012-9842-7. Epub 2012 Aug 14.

Supplemental Content

Loading ...
Support Center